Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Building Blocks. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112778162B details a mild Wolff rearrangement route for chiral beta-(Boc-amino)-5-hexynoic acid, offering high purity and scalable API intermediate manufacturing.
Advanced synthesis of optically pure 2-methyl alkyl glycol derivatives from lactones. Reliable supplier for pharma intermediates offering cost-effective, scalable chiral building blocks.
Patent CN100548965C details scalable synthesis of optically pure omega-hydroxy acid derivatives from steroidal sapogenin waste, offering cost-effective chiral building blocks.
Advanced preparation method for optically pure 2-methyl alkyl glycol derivatives from lactones. Enables scalable production of chiral synthetic building blocks for pharmaceutical and agrochemical intermediates.
Patent CN108752309B reveals a green C60/ZnO/Se catalytic method for glyceraldehyde acetonide, offering high purity and scalable production for pharmaceutical intermediates.
High-yield, high-ee synthesis of non-natural amino acids with water as proton source. Reduce production costs and supply chain risks for API manufacturing.